This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 1998 Aug;12(8):1327-8.

doi: 10.1038/sj.leu.2401096.

Both P-gp and MRP contribute to drug resistance in AML

O Legrand, G Simonin, R Zittoun, J P Marie

PMID: 9697893
DOI: 10.1038/sj.leu.2401096

Comment

Both P-gp and MRP contribute to drug resistance in AML

O Legrand et al. Leukemia. 1998 Aug.

. 1998 Aug;12(8):1327-8.

doi: 10.1038/sj.leu.2401096.

Authors

O Legrand, G Simonin, R Zittoun, J P Marie

PMID: 9697893
DOI: 10.1038/sj.leu.2401096

No abstract available

PubMed Disclaimer

Comment on

Multicentric evaluation of the MDR phenotype in leukemia. French Network of the Drug Resistance Intergroup, and Drug Resistance Network of Assistance Publique-Hôpitaux de Paris.
Marie JP, Huet S, Faussat AM, Perrot JY, Chevillard S, Barbu V, Bayle C, Boutonnat J, Calvo F, Campos-Guyotat L, Colosetti P, Cazin JL, de Cremoux P, Delvincourt C, Demur C, Drenou B, Fenneteau O, Feuillard J, Garnier-Suillerot A, Genne P, Gorisse MC, Gosselin P, Jouault H, Lacave R, Robert J, et al. Marie JP, et al. Leukemia. 1997 Jul;11(7):1086-94. doi: 10.1038/sj.leu.2400656. Leukemia. 1997. PMID: 9204996

Similar articles

Novel mechanisms of drug resistance in leukemia.
Ross DD. Ross DD. Leukemia. 2000 Mar;14(3):467-73. doi: 10.1038/sj.leu.2401694. Leukemia. 2000. PMID: 10720143 Review.
Transporter molecules in multidrug resistance.
Scheper RJ, Scheffer GL, Flens MJ, van der Valk P, Broxterman HJ, Izquierdo MA. Scheper RJ, et al. Cytotechnology. 1996;19(3):187-90. doi: 10.1007/BF00744211. Cytotechnology. 1996. PMID: 8862005 Review. No abstract available.
P-glycoprotein and multidrug resistance protein activities in relation to treatment outcome in acute myeloid leukemia.
van der Kolk DM, de Vries EG, van Putten WJ, Verdonck LF, Ossenkoppele GJ, Verhoef GE, Vellenga E. van der Kolk DM, et al. Clin Cancer Res. 2000 Aug;6(8):3205-14. Clin Cancer Res. 2000. PMID: 10955805
Evaluation of the clinical relevance of the expression and function of P-glycoprotein, multidrug resistance protein and lung resistance protein in patients with primary acute myelogenous leukemia.
Tsimberidou AM, Paterakis G, Androutsos G, Anagnostopoulos N, Galanopoulos A, Kalmantis T, Meletis J, Rombos Y, Sagriotis A, Symeonidis A, Tiniakou M, Zoumbos N, Yataganas X. Tsimberidou AM, et al. Leuk Res. 2002 Feb;26(2):143-54. doi: 10.1016/s0145-2126(01)00106-0. Leuk Res. 2002. PMID: 11755464
Inhibition of the P-glycoprotein- and multidrug resistance protein-mediated efflux of anthracyclines and calceinacetoxymethyl ester by PAK-104P.
Marbeuf-Gueye C, Salerno M, Quidu P, Garnier-Suillerot A. Marbeuf-Gueye C, et al. Eur J Pharmacol. 2000 Mar 17;391(3):207-16. doi: 10.1016/s0014-2999(00)00047-9. Eur J Pharmacol. 2000. PMID: 10729360

See all similar articles

Cited by

Diagnostics of multidrug resistance in cancer.
Szakács G, Jakab K, Antal F, Sarkadi B. Szakács G, et al. Pathol Oncol Res. 1998;4(4):251-7. doi: 10.1007/BF02905214. Pathol Oncol Res. 1998. PMID: 9887354 Review.
Sodium butyrate and panobinostat induce apoptosis of chronic myeloid leukemia cells via multiple pathways.
Jia X, Zheng Y, Guo Y, Chen K. Jia X, et al. Mol Genet Genomic Med. 2019 May;7(5):e613. doi: 10.1002/mgg3.613. Epub 2019 Mar 19. Mol Genet Genomic Med. 2019. PMID: 30891950 Free PMC article.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Miscellaneous
- NCI CPTAC Assay Portal